Immune Therapeutics (IMUN) News Today $0.09 0.00 (0.00%) As of 10/19/2023 Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Immune Repertoire Sequencing Market worth US$560.5 million by 2030 with 9.6% CAGR | MarketsandMarketsApril 17 at 11:19 PM | finanznachrichten.de'Time machine' enzyme could improve mRNA-based therapeuticsApril 17 at 11:19 PM | msn.comRecently Discovered Immune Cell Type Is Key to Understanding Food AllergiesApril 14, 2025 | finance.yahoo.comPotential Alzheimer's disease therapeutic target identified in brain immune cellsApril 9, 2025 | msn.comWorld's First Immune Cell Atlas From Diverse Asian Populations Empowers Precision MedicineApril 9, 2025 | msn.comImmune Molecules May Influence Behavior During IllnessApril 8, 2025 | msn.comIntestinal immune cell found to prevent food allergies in miceApril 3, 2025 | msn.comGrant awarded to Institute scientist will support development of immune-enhancing therapeuticMarch 21, 2025 | yahoo.comFDA recognizes need for immunogenicity assays in therapeutics with carriers or conjugatesMarch 3, 2025 | msn.comImmune-Onc doses first subject in trial of IO-108 for HCCFebruary 28, 2025 | finance.yahoo.comImmune cells convert bacteria into critical nutrients, scientists discoverFebruary 26, 2025 | msn.comDisruption of Immune Cells Linked to Cancer Outcomes, New Tool ShowsFebruary 18, 2025 | msn.comGlobal Immune Checkpoint Inhibitors Market to Cross USD 100 Billion by 2032 | DelveInsightFebruary 18, 2025 | finance.yahoo.comPancreatic cancer immune landscape reveals opportunities for personalized therapiesFebruary 7, 2025 | msn.comCentury Therapeutics Partners with Experts for New Trial on Autoimmune DiseasesJanuary 25, 2025 | msn.comImmune environment found to influence success of leukemia immunotherapyJanuary 25, 2025 | msn.comCancer researchers shed light on how immune cell clusters formJanuary 16, 2025 | msn.comSave Money With These DIY Immune Booster Shots — Recipes From DietitiansJanuary 14, 2025 | msn.comScientists engineer CRISPR enzymes that evade immune systemJanuary 9, 2025 | msn.comFoundery Immune Studio, LLC Acquires Rights to a Suite of Next-Generation Clinical Stage ImmunotherapiesJanuary 9, 2025 | finance.yahoo.comCytoMed, a Singapore Biotech, Revolutionizes Cancer Treatment Using Donor Immune CellsJanuary 6, 2025 | usatoday.comPortage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, LtdDecember 17, 2024 | markets.businessinsider.comPortage Biotech Signs LOI With Immunova For Option To Acquire IOx Therapeutics; Stock Soars 200%December 17, 2024 | markets.businessinsider.comImmune Health Supplements Market to hit USD 58 billion by 2032, says Global Market Insights Inc.December 4, 2024 | finance.yahoo.comSmart Immune and CELLforCURE by SEQENS Partner to Industrialize SMART101 Clinical Batches ManufacturingDecember 3, 2024 | finance.yahoo.comValora Therapeutics Raises $30 Million Seed Financing from Top Investors to Transform Immunotherapy with a Novel Glyco-immune Checkpoint PlatformNovember 21, 2024 | businesswire.comAn Update on Therapeutics for COVID-19November 17, 2024 | msn.comIndaptus Therapeutics’ Pioneering Research on Novel Immunotherapy Approach Published in Peer-Reviewed Frontiers in ImmunologyNovember 12, 2024 | markets.businessinsider.comIndaptus Therapeutics publishes research in Frontiers in ImmunologyNovember 12, 2024 | markets.businessinsider.comTempus Announces the Clinical Launch of its Immune Profile Score Algorithmic TestNovember 7, 2024 | finance.yahoo.comResearchers uncover immune mechanism behind myocarditis from cancer immunotherapyNovember 7, 2024 | msn.comWerewolf Therapeutics Presents Preclinical and Clinical Data at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual MeetingNovember 7, 2024 | markets.businessinsider.comAbbVie, EvolveImmune Therapeutics Set Cancer Biotherapeutics CollaborationNovember 2, 2024 | marketwatch.comEarly T Cell Changes in Cancer Immunotherapy Patients Tied to Severe Immune Side EffectsOctober 25, 2024 | msn.comHiya Announces Kids Daily Immune Expanding Healthy Offerings for KidsOctober 23, 2024 | finance.yahoo.comSmart Immune Announces Recommended SMART101 Dose for Adult Cancer Proof-of-Concept TrialsOctober 23, 2024 | uk.finance.yahoo.comContext Therapeutics to Showcase Promising Cancer Therapy at SITC Annual MeetingOctober 17, 2024 | msn.comUnveiling immune system responses that induce and maintain autoimmune pancreatitisOctober 9, 2024 | msn.comNew insights into immune mechanisms that prevent cancer metastasisOctober 8, 2024 | msn.comSYNEVIT® Has the Ideal Immune-Boosting Vitamin D3 SupplementOctober 3, 2024 | finance.yahoo.comAttivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapiesOctober 2, 2024 | markets.businessinsider.comNew mechanism uncovered behind immune decline after tuberculosis treatmentOctober 1, 2024 | msn.comImmune Checkpoint Inhibitors Market to hit USD 189.1 billion by 2032, says Global Market Insights Inc.October 1, 2024 | finance.yahoo.comDietary antigens reduce small intestine cancer by boosting immune T-cellsSeptember 25, 2024 | msn.comReview: 'Twilight of the Gods' Isn't Immune To Zack Snyder's Worst ImpulsesSeptember 19, 2024 | msn.comAging immune system fuels cancer growthSeptember 6, 2024 | msn.comImmune Heroes | Dr. Namita GandhiSeptember 5, 2024 | msn.comNo, COVID-19 vaccines do not 'eat' children's immune systems | Fact checkAugust 30, 2024 | usatoday.comExploring key regulators of programmed cell death in melanoma and the immune system's responseAugust 29, 2024 | msn.comNIH grants funds to Boston Immune’s Phase I trial of TNFR2 antagonistAugust 20, 2024 | msn.com Get Immune Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for IMUN and its competitors with MarketBeat's FREE daily newsletter. Email Address IMUN Media Mentions By Week IMUN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMUN News Sentiment▼0.400.53▲Average Medical News Sentiment IMUN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMUN Articles This Week▼31▲IMUN Articles Average Week Get Immune Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for IMUN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Atara Biotherapeutics News VolitionRx News Marinus Pharmaceuticals News MariMed News Allakos News Surrozen News Kezar Life Sciences News LAVA Therapeutics News Akari Therapeutics News Barinthus Biotherapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:IMUN) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immune Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immune Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.